Company performance
Add to research
Current Price
as of Apr 24, 2025$29.26
P/E Ratio
2.51
Market Cap
$1.68B
Description
Add to research
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Metrics
Add to research
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerAGIO
- Price$29.26+3.14%
Trading Information
- Market cap$1.68B
- Float96.28%
- Average Daily Volume (1m)678,513
- Average Daily Volume (3m)681,083
- EPS$11.86
Company
- Revenue$36.50M
- Rev growth (1yr)36.07%
- Net income$673.73M
- Gross margin73.10%
- EBITDA margin-1,150.98%
- EBITDA-$420.08M
- EV$1.07B
- EV/Revenue29.19
- P/E2.51
- P/S46.41
- P/B1.09
- Debt/Equity3.70
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset